7th Circ. Urged To Revive Suit Over Abbott Off-Label Scheme

By Lance Duroni (February 20, 2015, 3:41 PM EST) -- Three health benefit plans on Friday pressed the Seventh Circuit to revive their proposed class action seeking to recover hundreds of millions of dollars allegedly lost through Abbott Laboratories Inc.'s scheme to promote its drug Depakote for ineffective off-label uses and hand out kickbacks to prescribing doctors, arguing their racketeering claims weren't time-barred....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!